Preclinical vaccine study of Plasmodium vivax circumsporozoite protein derived-synthetic polypeptides formulated in montanide ISA 720 and montanide ISA 51 adjuvants.
about
Platform for Plasmodium vivax vaccine discovery and developmentPhase I safety and immunogenicity trial of Plasmodium vivax CS derived long synthetic peptides adjuvanted with montanide ISA 720 or montanide ISA 51Long-term humoral and cellular immune responses elicited by a heterologous Plasmodium vivax apical membrane antigen 1 protein prime/adenovirus boost immunization protocol.Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175.Efficacy of a Plasmodium vivax malaria vaccine using ChAd63 and modified vaccinia Ankara expressing thrombospondin-related anonymous protein as assessed with transgenic Plasmodium berghei parasites.Molecular and immunological tools for the evaluation of the cellular immune response in the neotropical monkey Saimiri sciureus, a non-human primate model for malaria research.Vaccine Containing the Three Allelic Variants of the Plasmodium vivax Circumsporozoite Antigen Induces Protection in Mice after Challenge with a Transgenic Rodent Malaria Parasite.Prime-boost vaccination with recombinant protein and adenovirus-vector expressing Plasmodium vivax circumsporozoite protein (CSP) partially protects mice against Pb/Pv sporozoite challenge.
P2860
Q27021891-1F7CC57B-7D2F-484A-A9BA-D96DD47501B7Q34546201-DDF21DD4-8164-4253-B555-1BBEFBFCD0E0Q35191980-BD32F3F9-A75E-444C-BB24-53297D5D6237Q35557657-CF51F6BD-DD60-4582-9C02-F9BD18A75F93Q37643867-12B15745-37DD-46AD-8AC2-94FFEC407FE4Q40144992-2980C979-680B-45D3-8D68-D09B2B05AD70Q42699604-32F65230-B55B-4E04-90B4-FAB921670771Q48022505-71054BDE-CBD5-4A80-A1ED-42540142EA72
P2860
Preclinical vaccine study of Plasmodium vivax circumsporozoite protein derived-synthetic polypeptides formulated in montanide ISA 720 and montanide ISA 51 adjuvants.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Preclinical vaccine study of P ...... nd montanide ISA 51 adjuvants.
@ast
Preclinical vaccine study of P ...... nd montanide ISA 51 adjuvants.
@en
Preclinical vaccine study of P ...... nd montanide ISA 51 adjuvants.
@nl
type
label
Preclinical vaccine study of P ...... nd montanide ISA 51 adjuvants.
@ast
Preclinical vaccine study of P ...... nd montanide ISA 51 adjuvants.
@en
Preclinical vaccine study of P ...... nd montanide ISA 51 adjuvants.
@nl
prefLabel
Preclinical vaccine study of P ...... nd montanide ISA 51 adjuvants.
@ast
Preclinical vaccine study of P ...... nd montanide ISA 51 adjuvants.
@en
Preclinical vaccine study of P ...... nd montanide ISA 51 adjuvants.
@nl
P2093
P2860
P1476
Preclinical vaccine study of P ...... nd montanide ISA 51 adjuvants.
@en
P2093
Angélica Castellanos
Liliana Soto
Myriam Arévalo-Herrera
Nora Céspedes
Omaira Vera
Sócrates Herrera
P2860
P356
10.4269/AJTMH.2011.10-0110
P407
P433
P577
2011-02-01T00:00:00Z